Top compounds associated with response to OR5L2


Feature Type Standardized
Nominal ANOVA
mRNA HG-5-88-01 GDSC1000 pan-cancer AAC -0.055 0.2
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC -0.045 0.2
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.043 0.2
mRNA oligomycin a CTRPv2 pan-cancer AAC -0.042 0.2
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.2
mRNA lovastatin CTRPv2 pan-cancer AAC -0.043 0.2
mRNA CAY10576 CTRPv2 pan-cancer AAC -0.046 0.2
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.043 0.2
mRNA ML210 CTRPv2 pan-cancer AAC 0.038 0.2
mRNA JW-74 CTRPv2 pan-cancer AAC 0.053 0.2
Download CSV